Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetrorelix in moderate to severe rheumatoid arthritis
NCT00667758Phase 2Completed
- Sponsor
- Betanien Hospital
- Start
- May 2008
- Primary completion
- Jun 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cetrorelix in rheumatoid arthritis (RA), sponsored by Betanien Hospital. Started May 2008; status: completed.
02
Drugs
cetrorelix
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00667758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00667758.